The pause of the Johnson & Johnson vaccine after six cases of serious illness among 7 million vaccinated people shows how a federal panel weighs the risks and benefits of medical protection that might also cause severe harm.
Read more via AAMCNews: Is it safe? How experts assessed J&J's suspended COVID-19 vaccine
Editor's note: On April 23 the federal advisory panel described in this article recommended the resumption of J&J vaccinations, with an update to the vaccine label about risks of a rare, but serious, blood clotting condition in women under 50.
------------------------------
Stephanie Weiner
Director, Digital Strategy & Engagement
Association of American Medical Colleges
------------------------------